Register Now

For News and Event Updates direct to your email inbox.

You are here

Rituximab/MabThera Questionnaire

Sunday, 22 April 2018

The drug Rituximab, otherwise known as MabThera, appears to be a more regularly considered treatment option for people with Myasthenia Gravis. Access to this drug varies greatly depending on each individual situation.

The Myasthenia Alliance Australia Committee is interested in learning more about accessing difficulties Australians are facing. We ask that anyone in Australia who has been offered, or is currently receiving this drug treatment, please complete a questionnaire. Your urgent response is needed.

Please go to this link to participate: